X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (29975) 29975
Book Chapter (297) 297
Magazine Article (225) 225
Newsletter (108) 108
Newspaper Article (55) 55
Book / eBook (35) 35
Conference Proceeding (20) 20
Publication (17) 17
Dissertation (16) 16
Web Resource (12) 12
Reference (2) 2
Government Document (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (25684) 25684
heparin - therapeutic use (16614) 16614
science & technology (14909) 14909
life sciences & biomedicine (14223) 14223
female (12312) 12312
male (11321) 11321
anticoagulants - therapeutic use (9352) 9352
middle aged (8013) 8013
adult (6847) 6847
heparin (6818) 6818
aged (6414) 6414
abridged index medicus (5202) 5202
heparin, low-molecular-weight - therapeutic use (4989) 4989
cardiovascular system & cardiology (4485) 4485
animals (3910) 3910
heparin - administration & dosage (3788) 3788
heparin - adverse effects (3677) 3677
anticoagulants (3603) 3603
treatment outcome (3090) 3090
fibrinolytic agents - therapeutic use (3023) 3023
hematology (2959) 2959
anticoagulants - adverse effects (2943) 2943
risk factors (2806) 2806
peripheral vascular disease (2708) 2708
cardiac & cardiovascular systems (2431) 2431
anticoagulants - administration & dosage (2381) 2381
pregnancy (2295) 2295
general & internal medicine (2226) 2226
time factors (2160) 2160
thrombosis (2033) 2033
surgery (1939) 1939
heparin - pharmacology (1776) 1776
warfarin - therapeutic use (1772) 1772
thromboembolism - prevention & control (1770) 1770
thrombocytopenia - chemically induced (1706) 1706
aspirin - therapeutic use (1698) 1698
medicine, general & internal (1692) 1692
postoperative complications - prevention & control (1692) 1692
prospective studies (1670) 1670
aged, 80 and over (1642) 1642
adolescent (1626) 1626
retrospective studies (1610) 1610
thromboembolism (1563) 1563
drug therapy, combination (1528) 1528
pharmacology & pharmacy (1470) 1470
pulmonary embolism - drug therapy (1433) 1433
thrombosis - prevention & control (1424) 1424
thrombosis - drug therapy (1416) 1416
hemorrhage - chemically induced (1407) 1407
myocardial infarction - drug therapy (1311) 1311
venous thrombosis - drug therapy (1270) 1270
platelet aggregation inhibitors - therapeutic use (1268) 1268
care and treatment (1214) 1214
acute disease (1173) 1173
thrombophlebitis - drug therapy (1163) 1163
blood coagulation tests (1131) 1131
heparin, low-molecular-weight - administration & dosage (1127) 1127
drug therapy (1121) 1121
heparin, low-molecular-weight - adverse effects (1119) 1119
child (1111) 1111
venous thrombosis - prevention & control (1111) 1111
follow-up studies (1102) 1102
glycosaminoglycans (1091) 1091
recurrence (1090) 1090
health aspects (1089) 1089
pulmonary embolism - prevention & control (1088) 1088
dose-response relationship, drug (1073) 1073
blood coagulation - drug effects (1061) 1061
clinical trials as topic (1061) 1061
medicine & public health (1061) 1061
thrombolytic therapy (1031) 1031
recombinant proteins - therapeutic use (1015) 1015
thrombophlebitis - prevention & control (1015) 1015
analysis (1005) 1005
rats (994) 994
venous thromboembolism (975) 975
thrombosis - etiology (970) 970
pulmonary embolism (952) 952
anticoagulation (936) 936
partial thromboplastin time (936) 936
research (930) 930
anticoagulants - pharmacology (927) 927
randomized controlled trials as topic (893) 893
thromboembolism - drug therapy (891) 891
streptokinase - therapeutic use (881) 881
low molecular weight heparin (859) 859
venous thromboembolism - prevention & control (835) 835
mice (811) 811
low-molecular-weight heparin (805) 805
warfarin (778) 778
enoxaparin - therapeutic use (777) 777
thrombocytopenia (733) 733
injections, subcutaneous (729) 729
risk assessment (726) 726
pulmonary embolism - etiology (718) 718
patients (711) 711
molecular weight (702) 702
cancer (697) 697
incidence (696) 696
infant, newborn (696) 696
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (28) 28
Online Resources - Online (14) 14
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Pharmacy (1) 1
Credit Valley Hospital - Closed Orders (1) 1
Gerstein Science - Pharmacy (1) 1
Gerstein Science - Theses (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Online (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (25702) 25702
German (1635) 1635
French (1331) 1331
Russian (711) 711
Spanish (418) 418
Italian (383) 383
Japanese (283) 283
Polish (196) 196
Chinese (162) 162
Portuguese (78) 78
Danish (64) 64
Dutch (64) 64
Hungarian (55) 55
Romanian (54) 54
Czech (52) 52
Bulgarian (39) 39
Swedish (37) 37
Norwegian (35) 35
Ukrainian (28) 28
Finnish (26) 26
Croatian (22) 22
Hebrew (19) 19
Slovak (19) 19
Serbian (16) 16
Turkish (16) 16
Afrikaans (5) 5
Korean (5) 5
Lithuanian (5) 5
Bosnian (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Thrombosis and Haemostasis, ISSN 0340-6245, 09/2015, Volume 113, Issue 5, pp. 931 - 942
Journal Article
The American heart journal, ISSN 0002-8703, 11/2014, Volume 168, Issue 5, pp. 611 - 621
.... Anticoagulation uses 1 of 4 choices: bivalirudin, unfractionated heparin, enoxaparin, and fondaparinux... 
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Recombinant Proteins - therapeutic use | Prasugrel Hydrochloride | Thiophenes - therapeutic use | Hirudins | Humans | Heparin - therapeutic use | Enoxaparin - therapeutic use | Tyrosine - analogs & derivatives | Receptors, Thrombin - antagonists & inhibitors | Warfarin - therapeutic use | Tyrosine - therapeutic use | Adenosine - therapeutic use | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Purinergic P2Y Receptor Antagonists - therapeutic use | Pyridines - therapeutic use | Polysaccharides - therapeutic use | Anticoagulants - therapeutic use | Piperazines - therapeutic use | Adenosine Monophosphate - therapeutic use | Lactones - therapeutic use | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Acute Coronary Syndrome - drug therapy | Adenosine - analogs & derivatives | Adenosine Monophosphate - analogs & derivatives | Peptide Fragments - therapeutic use | Peptides - therapeutic use | Aspirin | Glycosaminoglycans | Atrial fibrillation | Mortality | Thrombin | Anticoagulants (Medicine) | Health aspects | Drug approval | Coronary heart disease | Heart attacks | Acute coronary syndromes | Drug therapy | Clinical outcomes | Index Medicus | Abridged Index Medicus
Journal Article
American Journal of Medicine, The, ISSN 0002-9343, 2016, Volume 129, Issue 11, pp. S47 - S53
Journal Article
Circulation (New York, N.Y.), ISSN 0009-7322, 08/2004, Volume 110, Issue 9, pp. 1061 - 1068
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 02/2003, Volume 289, Issue 7, pp. 853 - 863
Journal Article
Circulation (New York, N.Y.), ISSN 0009-7322, 07/2007, Volume 116, Issue 5, pp. 552 - 560
Cardiac & Cardiovascular Systems | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Fibrinolytic Agents - classification | Recombinant Proteins - therapeutic use | Thiophenes - therapeutic use | Pyrazoles - therapeutic use | Benzylamines - adverse effects | Factor Xa Inhibitors | Anticoagulants - classification | Humans | Thrombin - antagonists & inhibitors | Heparin, Low-Molecular-Weight - therapeutic use | Warfarin - therapeutic use | Fibrinolytic Agents - adverse effects | Rivaroxaban | Pyridines - adverse effects | Angina, Unstable - drug therapy | Prothrombin - antagonists & inhibitors | Hirudins - pharmacokinetics | Morpholines - therapeutic use | Benzimidazoles - therapeutic use | Polysaccharides - therapeutic use | Azetidines - adverse effects | Peptide Fragments - pharmacokinetics | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Forecasting | Azetidines - therapeutic use | Brain Ischemia - drug therapy | Peptide Fragments - therapeutic use | Benzylamines - pharmacokinetics | Hemorrhage - chemically induced | Heparin - therapeutic use | Recombinant Proteins - pharmacokinetics | Dabigatran | Fibrinolytic Agents - pharmacokinetics | Fibrinolytic Agents - therapeutic use | Thrombosis - prevention & control | Benzimidazoles - adverse effects | Thrombophilia - drug therapy | Pyridines - therapeutic use | Azetidines - pharmacokinetics | Clinical Trials as Topic | Coumarins - therapeutic use | Polysaccharides - pharmacology | Thiophenes - pharmacokinetics | Myocardial Infarction - drug therapy | Anticoagulants - pharmacokinetics | Pyridones - therapeutic use | Thrombosis - drug therapy | Morpholines - pharmacokinetics | Benzylamines - therapeutic use | Physiological aspects | Usage | Warfarin | Heparin | Index Medicus | Abridged Index Medicus
Journal Article